| Literature DB >> 34928590 |
Phil Borman1, Cristiana Campa2, Ghislain Delpierre3, Elliot Hook4, Patrick Jackson1, Wayne Kelley5, Michel Protz3, Olivier Vandeputte3.
Abstract
A structured approach to method development can help to ensure an analytical procedure is robust across the lifecycle of its use. The analytical target profile (ATP), which describes the required quality of the reportable value to be produced by the analytical procedure, enables the analytical scientist to select the best analytical technology on which to develop their procedure(s). Once the technology has been identified, screening of potentially fit for purpose analytical procedures should take place. Analytical procedures that have been demonstrated to meet the ATP should be evaluated against business drivers (e.g., operational constraints) to determine the most suitable analytical procedure. Three case studies are covered from across small molecules, vaccines, and biotherapeutics. The case studies cover different aspects of the analytical procedure selection process, such as the use of platform method development processes and procedures, the development of multiattribute analytical procedures, and the use of analytical technologies to provide product characterization knowledge in order to define or redefine the ATP. Challenges associated with method selection are discussed such as where existing pharmacopoeial monographs link acceptance criteria to specific types of analytical technology.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34928590 DOI: 10.1021/acs.analchem.1c03854
Source DB: PubMed Journal: Anal Chem ISSN: 0003-2700 Impact factor: 6.986